Tonix Pharmaceuticals Holding Corp.

News & Events

Press Releases

In The Media

1. Tonix Pharmaceuticals Announces Presentation at the A.G.P. Annual Healthcare Company Showcase

   GlobeNewswire MAY 22, 2025 7:00 AM EDT
   CHATHAM, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP...
   READ ARTICLE

2. Tonix Pharmaceuticals Announces First Patient Dosed in Phase 2 OASIS Study of TNX-102 SL for Reduction of Acute Stress Reaction

   GlobeNewswire MAY 21, 2025 7:00 AM EDT
   Investigator-initiated Phase 2 trial to evaluate TNX-102 SL’s potential to reduce severity...
   READ ARTICLE

3. Tonix Pharmaceuticals Announces Appointment of Joseph Hand, Esq., as General Counsel and Executive Vice President of Operations

   GlobeNewswire MAY 14, 2025 7:00 AM EDT
   Mr. Hand brings more than 20 years of strategic legal and business leadership experience across m...
   READ ARTICLE

4. Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights

   GlobeNewswire MAY 12, 2025 4:30 PM EDT
   FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if app...
   READ ARTICLE

5. Tonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual Meeting

   GlobeNewswire APR 29, 2025 9:05 AM EDT
   Combination treatment of TFF2 with anti-PD1 antibody was associated with the activation of cancer...
   READ ARTICLE

6. Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025

   GlobeNewswire APR 24, 2025 7:55 AM EDT
   TNX-801 is a single-dose, live virus vaccine in development to protect against mpox and small...
   READ ARTICLE

7. Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025

   GlobeNewswire APR 16, 2025 7:00 AM EDT
   CHATHAM, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TN...
   READ ARTICLE

8. Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix's Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana's Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies

   GlobeNewswire APR 9, 2025 7:00 AM EDT
   Agreement includes the use of Tonix’s TNX-1500, as part of an immunomodulatory regimen to ...
   READ ARTICLE

9. Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American Academy of Pain Medicine (AAPM) 2025 Annual Meeting

   GlobeNewswire APR 7, 2025 7:00 AM EDT
   TNX-102 SL is a sublingual formulation of cyclobenzaprine designed for transmucosal delivery and ...
   READ ARTICLE

10. Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference

    GlobeNewswire APR 2, 2025 7:00 AM EDT
    CHATHAM, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TN...
    READ ARTICLE